Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OneAlphaMed is a pharmaceutical-focused marketing and medical communications agency that operates primarily across India, Southeast Asia, and global markets. The company specializes in bridging the gap between clinical innovation and patient recovery through AI-driven automation and bespoke scientific communication solutions. Their core services include pre-launch brand strategy, medical affairs, digital innovation, and patient advocacy programs. OneAlphaMed leverages its proprietary MERLIN AI platform, a retrieval-augmented generation model trained on verified medical literature, to deliver evidence-based content and streamline healthcare professional engagement. With a network of over 5,000 key opinion leaders, the agency supports global pharmaceutical leaders in scaling their impact and improving therapy adoption.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on One-Alpha.